Logo Background RSS

Advertisement

Notable Analyst Rating Changes 02/26: RST, AZN/GSK, CHA/CHU, OSIS, LAMR Upgraded; PALM, DPS, ATHN, FLR, MOT Downgraded

  • Written by admin | No Comments Comments
    Last Updated: February 27th, 2010

    UPGRADES
    Jefferies & Co upgrades Rosetta Stone (NYSE: RST) from Hold to Buy. Price target raised from $24 to $29.

    Goldman Sachs upgrades two pharma’s from Sell to Neutral:

    • AstraZeneca plc (NYSE: AZN); and

    • GlaxoSmithKline plc (NYSE: GSK). Click Here for more color.

    Deutsche Bank upgrades China Unicom (NYSE: CHU) and China Telecom (NYSE: CHA) from Hold to Buy. Think China Unicom is one of their top picks in China TMT space.

    Morgan Keegan upgrades OSI Systems (NASDAQ: OSIS) from Market Perform to Outperform.

    Lamar Advertising (NASDAQ: LAMR) gets two upgrades today:

    • J.P. Morgan to Overweight from Neutral and a price target increased to

Advertisement

Leave a Comment